This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on May 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Notice of Intent to Award to Sole Source - FSE On-Site Annual Preventative Maintenance

Closed

97963Federal

Submission Closed05/29/2026, 12:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

Federal

Blood Testing and Laboratory Services

247-NETWORK Contract Office 7 (36C247)

POSTED

DEADLINE

Olink Explore HT Reagent Kit Supplier

National Institutes Of Health Olao

POSTED

DEADLINE

Solicitation # 36C25727Q0016

The Department of Veterans Affairs, Network Contracting Office 17, is issuing a Sources Sought Notice to identify capable providers for a fully automated gel electrophoresis instrument. The equipment will be used by the Pathology and Laboratory Medicine Service at the Audie L. Murphy Memorial VA Hospital in San Antonio, Texas, to perform serum and urine electrophoresis, immunofixation, and immunotyping to identify monoclonal and polyclonal gammopathies. This notice is for planning purposes only and does not constitute a formal solicitation or an obligation to award a contract. Interested parties must submit their company name, point of contact, SAM UEI or DUNS number, socio-economic status, and a capability statement to Jose Campa by September 22, 2026, at 10:00 AM CST. The government will use the responses to determine if there are sufficient small business concerns capable of fulfilling the requirement.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

TEST KIT, CHLAMYDIA TRA

Solicitation # SPE2DS-26-T-423P

Solicitation SPE2DS-26-T-423P, issued by the DLA Troop Support Medical Supply Chain, is a request for quotes for one test kit for the detection of Chlamydia trachomatis, identified by NSN 6550-01-725-3600. The kit is designed for in vitro diagnostic use to perform qualitative direct immunofluorescence tests on human urogenital and ophthalmic specimens, as well as for confirming Chlamydia in cell culture. Each kit must provide materials for 50 tests and include two positive control slides, mounting fluid, Chlamydia test reagent, and instructions for use. The required delivery date is September 14, 2026, with the place of performance and delivery located in San Antonio, Texas. The procurement falls under NAICS code 325413 and is subject to destination inspection and acceptance. Packaging must adhere to commercial standards, MIL-STD-2073-1E, and RP001, while marking must comply with Medical Marking Standard No. 1. The contract incorporates various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and the Hazard Communication Standard for hazardous materials. Payment and invoicing are to be processed electronically through the Wide Area WorkFlow system. Quotes must be submitted via the DIBBS portal by September 16, 2026, and the award may be processed through an automated system, with a price evaluation preference applied to HUBZone concerns.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-421Y

Solicitation SPE2DS-26-T-421Y is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. The kits, identified by NSN 6550-01-716-1573, must be delivered to the USNS John L. Canley T-ESB-6 in San Diego, California. Each case contains 12 kits with two tests per kit. The items are subject to a non-extendable shelf life of 12 months, and no more than one month may have elapsed from the date of manufacture to the date of delivery to the government. The contractor must adhere to strict storage and marking requirements, maintaining the kits between 2-30 degrees Celsius and labeling all materials according to Medical Marking Standard No. 1. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers in accordance with RP001 DLA Packaging Requirements. All labels must include the contract or lot number and the date of manufacture and expiration. Quotes must be submitted via the DIBBS system by September 16, 2026, and the award will be automated. Payment and receiving reports are to be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Blood Bank Reagents and Consumables Supply

POSTED

DEADLINE

Urine Drug Screening and Confirmation Laboratory Services

Residential Reentry - Co

POSTED

DEADLINE

Intent to Sole Source- Automated Blood Bank Instrumentation

Solicitation # PZIBABPA

The Air Force Life Cycle Management Center intends to award a sole-source, firm-fixed-price Blanket Purchase Agreement to QuidelOrtho Sales Company, LLC. This contract provides automated blood bank instrumentation, reagents, consumables, and associated support for the 88th Medical Group Laboratory Flight at Wright-Patterson Air Force Base. The requirement specifies a fully automated, continuous-access system that integrates with laboratory information systems, including MHS Genesis, to ensure uninterrupted blood bank operations. The decision to sole source follows extensive market research and a Sources Sought notice, which determined that QuidelOrtho is the only available source capable of meeting the minimum technical requirements. These requirements include specific methodology, FDA-approved reagent kits, and a single-platform solution for blood bank testing. The procurement falls under NAICS code 325413. Interested parties wishing to challenge the sole-source intent must submit a detailed capability statement to the designated points of contact by September 22, 2026.

POSTED

DEADLINE

Supplier of I-STAT PT Plus Control Reagent Level 2

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-26-T-415T

This contract is for the procurement of one box of PT Plus Control Reagent Level 2, used for coagulation testing with the i-STAT PT Plus cartridge on the i-STAT 1 Government Field Kit analyzer. The item is issued in boxes containing ten 1.0ml units and is identified by NSN 6550-01-725-6872. Delivery is required within 20 days after the order is placed. The reagent has a non-extendable shelf life of 12 months, and no more than one month may elapse between the date of manufacture and delivery to the government. Storage requires refrigeration between 2 to 8 degrees Celsius, and the product must not be frozen. All supplies must adhere to DLA packaging and medical marking standards, including specific labeling for manufacture and expiration dates, contract numbers, and lot numbers.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-26-T-415M

This contract is for the procurement of one box of i-STAT PT Plus Control Reagent Level 1, used for coagulation testing on the i-STAT 1 Government Field Kit blood gas analyzer. Each box contains ten 1.0 ml units. The item is subject to a non-extendable shelf life of 12 months, with a requirement that no more than one month passes between the date of manufacture and the date of delivery to the government. Proper refrigeration is required for storage between 2 to 8 degrees Celsius. The supplier must adhere to DLA packaging and medical marking standards, ensuring each unit is sealed and protected in commercial shipping containers. All labels must clearly state the contract number, lot number, and dates of manufacture and expiration. Delivery is required within 20 days after the order is placed. Bidders are required to specify the source and part number being supplied.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DS-26-T-409W

This contract is for the procurement of one benzene chip designed for use with a CMS analyzer. The chip features ten measurement capillaries filled with a substance-specific reagent system, providing a measuring range of 0.5 to 10.0 ppm and a total capacity of ten tests. The item is identified by NSN 6550-01-530-9389 and must be delivered within 20 days after the order is placed. The product is subject to a non-extendable shelf life of 24 months, with a requirement that no more than three months elapse between the date of manufacture and the date of delivery to the government. Packaging must meet commercial standards and be secured in sealed unit containers to prevent damage. All labeling and marking must comply with Medical Marking Standard No. 1, including the date of manufacture, expiration or retest date, and the contract or lot number.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

4 days ago

DEADLINE

in 2 days

AI Contract Overview

The CDC is preparing to award a sole source, firm fixed price contract to Cepheid for on-site annual preventative maintenance services for the GeneXpert DX system, a proprietary automated platform currently used to detect carbapenemase gene markers from rectal swabs and wastewater samples in support of public health surveillance. The decision to proceed without competition is based on the system’s proprietary configuration, including manufacturer-specific hardware, software, maintenance protocols, and warranty terms, which require authorized support to ensure uninterrupted operations, surge testing capacity, and consistency with ongoing laboratory workflows and comparative PCR analyses. Market research confirmed that Cepheid is the only source capable of providing compliant maintenance services for this integrated system without disrupting critical public health activities. Responses to this notice of intent must be submitted by May 29, 2026, to contract specialist Ruben Reyes at qmz3@cdc.gov, and are limited to vendors authorized by Cepheid to perform maintenance on the GeneXpert DX platform. Although this is not a competitive solicitation, all timely submissions will be reviewed by the government to determine whether a competitive procurement is necessary. The procurement falls under NAICS code 325413 for in-vitro diagnostic substance manufacturing and is being conducted under FAR Part 12.102, which permits sole source awards when only one source can meet the government’s unique requirements. The work will be performed at the CDC’s facility in Atlanta, Georgia, with ongoing services essential to sustaining the agency’s wastewater surveillance and infectious disease detection capabilities.

General Info

CDC awards sole source contract to Cepheid for GeneXpert DX system maintenance, ensuring continuity.

Agency

Department Of Health And Human Services → CDC Office Of Acquisition ServicesView Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

Atlanta, GA, 30329, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMay 14

Presolicitation

Response DeadlineMay 29

Deadline has passed

Submission Closed

05/29/2026, 12:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services

Contacts1 person available

OfficeATLANTA, GA, 30333, USA

Organization / Agency

Department Of Health And Human Services → CDC Office Of Acquisition Services

View Agency Profile

Office AddressATLANTA, GA, 30333, USA

Contacts

Ruben Reyes

contact@example.gov

Full Description

The Centers for Disease Control and Prevention (CDC) intends to award a sole source, firm fixed price contract to CEPHEID.

This contract action is being conducted in accordance with FAR Overhaul Part 12.102, Restricting Competition. The Government determined that only one source is reasonably available to meet the current requirement based on the proprietary nature of the existing system configuration, compatibility requirements, and continuity of ongoing operations. The North American Industry Classification System code for this procurement is 325413 - In-Vitro Diagnostic Substance Manufacturing. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive proposals; however, all responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist Ruben Reyes at qmz3@cdc.gov by 08:00AM, May 29, 2026.

The Government currently utilizes the Cepheid GeneXpert DX system, an automated platform used for rapid detection and analysis of carbapenemase gene markers from rectal swab specimens and wastewater samples in support of public health testing activities.

The GeneXpert DX system has been integrated into the existing laboratory workflow and supports continuity of operations, surge testing capabilities, and ongoing Healthcare Wastewater sampling efforts. The system is also used to support comparative analysis against standard PCR testing methodologies.

Due to the proprietary nature of the GeneXpert DX platform, including manufacturer-specific components, software, maintenance requirements, and warranty conditions, the Government is seeking sources capable of providing authorized support and maintenance services for the existing equipment configuration.

The Government conducted market research, including review of available vendor information and communication with existing maintenance support resources, to identify potential sources capable of supporting the current system. Responses are being requested from vendors authorized to provide maintenance and support services for the Cepheid GeneXpert DX platform.